BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1471165)

  • 1. Genetically determined differences in drug metabolism as a risk factor in drug toxicity.
    Eichelbaum M; Kroemer HK; Mikus G
    Toxicol Lett; 1992 Dec; 64-65 Spec No():115-22. PubMed ID: 1471165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphic drug metabolism.
    Relling MV
    Clin Pharm; 1989 Dec; 8(12):852-63. PubMed ID: 2689060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of genetic polymorphisms of drug metabolism.
    Meyer UA; Zanger UM
    Annu Rev Pharmacol Toxicol; 1997; 37():269-96. PubMed ID: 9131254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
    Clark DW
    Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced liver graft toxicity caused by cytochrome P450 poor metabolism.
    Kóbori L; Kõhalmy K; Porrogi P; Sárváry E; Gerlei Z; Fazakas J; Nagy P; Járay J; Monostory K
    Br J Clin Pharmacol; 2008 Mar; 65(3):428-36. PubMed ID: 18070218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms of drug metabolism.
    Meyer UA
    Fundam Clin Pharmacol; 1990; 4(6):595-615. PubMed ID: 1982880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reaction monitoring in Jena. Relevance of polymorphic drug metabolizing enzymes for inducing adverse drug reactions.
    Hippius M; Buchardt C; Farker K; Kuhn UD; Reimann IR; Hoffmann A
    Exp Toxicol Pathol; 2003 Jun; 54(5-6):417-21. PubMed ID: 12877354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphic drug oxidation in humans.
    Eichelbaum M
    Fed Proc; 1984 May; 43(8):2298-302. PubMed ID: 6714436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interindividual differences in the reaction to drugs and poisons].
    Meyer UA
    Ther Umsch; 1992 Feb; 49(2):97-101. PubMed ID: 1553631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation.
    Meyer UA; Gut J; Kronbach T; Skoda C; Meier UT; Catin T; Dayer P
    Xenobiotica; 1986 May; 16(5):449-64. PubMed ID: 2874666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Knowledge about metabolic capacity is important in drug therapy].
    Alván G; Dahl ML
    Lakartidningen; 1992 Feb; 89(6):382, 387-90. PubMed ID: 1738265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically determined adverse drug reactions involving metabolism.
    Lennard MS
    Drug Saf; 1993 Jul; 9(1):60-77. PubMed ID: 8347292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinically significant inherited differences in the mode of action of drugs].
    Meyer UA; Meier PJ
    Schweiz Med Wochenschr; 1982 May; 112(19):666-9. PubMed ID: 7100864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical consequences of polymorphic drug oxidation.
    Alván G
    Fundam Clin Pharmacol; 1991; 5(3):209-28. PubMed ID: 1937350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.
    Nebert DW; McKinnon RA; Puga A
    DNA Cell Biol; 1996 Apr; 15(4):273-80. PubMed ID: 8639263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylator genotype and arylamine-induced carcinogenesis.
    Hein DW
    Biochim Biophys Acta; 1988 Aug; 948(1):37-66. PubMed ID: 3293663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine.
    Hietanen E; Malaveille C; Camus AM; Béréziat JC; Brun G; Castegnaro M; Michelon J; Idle JR; Bartsch H
    Drug Metab Dispos; 1986; 14(1):118-26. PubMed ID: 2868854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic polymorphism in human drug metabolism].
    Yamazoe Y; Nagata K
    Nihon Yakurigaku Zasshi; 1993 Feb; 101(2):69-77. PubMed ID: 8454228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylation.
    Weber WW
    Birth Defects Orig Artic Ser; 1990; 26(1):43-65. PubMed ID: 2224079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry.
    Zanger UM; Raimundo S; Eichelbaum M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):23-37. PubMed ID: 14618296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.